Aclaris Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (48)

View All

Latest Posts

About This Stock More About This Stock
Aclaris Therapeutics Soars After Promising Study Against Rheumatoid Arthritis
Article By: Admiral Markets
Wednesday, January 20, 2021 7:45 AM EDT
During the trading day yesterday, Aclaris Therapeutics’ stock shot upwards with a rise of more than 200%.
In this article: ACRS
Read
Aclaris Therapeutics - Chart Of The Day
Article By: Jim Van Meerten
Monday, October 3, 2016 4:48 PM EDT
The Chart of the Day belongs to Aclaris Therapeutics.
In this article: ACRS
Read
U.S. IPOs Lacked Luster In 2015: Will 2016 Turn The Tables?
Article By: Zacks Investment Research
Sunday, January 10, 2016 6:19 PM EDT
U.S. Initial Public Offerings (IPOs) were a major disappointment in 2015. According to Renaissance Capital, 170 IPOs raised only $30 billion (275 in 2014), which is the lowest since 2009.
In this article: BABA, MXPT, FIT, ACRS, FDC
Read
Best IPOs Of 2015
Article By: Zacks Investment Research
Tuesday, December 29, 2015 6:08 AM EDT
This past year did not see any record-breaking IPO performances like 2014’s historic market debut of Alibaba Group Holdings Ltd. – it was the largest IPO ever – which raised $25 billion.
In this article: SHAK, MCRB, ACRS, COLL, AVGR
Read
Aclaris Therapeutics IPO: Consider Holding Off
Article By: Don Dion
Tuesday, October 6, 2015 9:29 PM EDT
Aclaris Therapeutics Inc. (ACRS) expects to raise $75 million in its upcoming IPO. ACRS filed for the IPO on August 17, 2015.
In this article: ACRS
Read
All Posts

Latest Tweets for $ACRS

No tweets yet!

PARTNER HEADLINES